期刊文献+

HBV X基因真核表达载体的构建研究

The Construction of HBV X Gene Eukaryotic Expression Vector
下载PDF
导出
摘要 目的:构建HBV X基因与pCDNA3.1相融合的高效真核表达载体,为进一步研究HBV X基因的功能奠定基础。方法:设计并合成HBV X基因的引物,从HBV DNA阳性的血清中,PCR扩增得到HBV X基因全序列,将其连接到真核表达载体pCDNA3.1上后,酶切图谱分析PCR检测和扩增产物序列分析等,鉴定所构建的真核表达载体。结果:以重组载体为模板扩增得到的片段大小与已知HBV X基因大小相同,酶切也得到目的基因片段,测序结果也显示与已知X基因序列相同。结论:成功构建了HBV X基因的真核表达载体,为下一步研究HBV X基因及其产物的功能奠定了基础。 Object:To construct a highly effective eukaryotic expression vector pCDNA3.1 with HBV X gene (pCDNA3.1 - X) for exploring the contribution of X gene to the chronic hepatitis and the bepatocellular. Methods:Abstract HBV DNA from the HBV DNA positive serum. HBV X gene was amplied by PCR, identified by gelose electrophoresis analysis. The PCRproduct and the eukaryotic expression vector pCDNA3.1 were digested by restruction endonucleases, then the digested X gene was inserted into the digested eukaryotic expressionvector. After screened, the positive recombinants were picked out. PCR analysis, Kpn I and EcoR Irestriction endonucleases digest analysis and sequence analysis were used to identify the recombinants. Results The 480bp DNA fragment was firstly amplified by PCR from the HBV DNA positive serumre. The identical DNA fragment was also amplified from the recombinants. The products of double restriction endonucleases digest analysis were X gene and a 5.5kb DNA fragment. Sequence analysis showed that the the HBV X gene was successfully inserted into pCDNA3, lvector. Conclusion:The eukaryotic expression vector pCDNA3.1 -X has been successfully constructed.
作者 魏魏 药泽蓉
出处 《长治医学院学报》 2006年第4期249-250,253,共3页 Journal of Changzhi Medical College
关键词 HBV 真核表达载体 PCDNA3.1 HBV Eukaryotic Expression Vector pCNA3.1
  • 相关文献

参考文献7

  • 1Clarke Berwyn and Bloor Stuart. Molecular genotyping of hepatitis B vlrus[J] .J of Clinic Virol,2002,25(3) :41 - 45.
  • 2Nomura T,Lin Y, Dorisuren D, et al . Human hepatitis B proteins detectable in nuclei of transfected cells,and is active transactivation[J].J Biophys Acta, 1999,1 453 (3) : 330.
  • 3Wang W, London WT, Feiterson MA. Hepatitis B antigen in hepatitis B virus cartier patients with cancer [J].Cancer Res, 1991,51:4 971 - 4 977.
  • 4Wang HD, Txixedi A,Johnson DL. Regulation of RNA polymerase Ⅰ -dependent promoters by the hepatitis B virus X protein ria activated Ras and TATA - binding proein. Mol cell Bid, 1998,18(12) :7086-7094.
  • 5Diao J,Khine AA,Samsl F, et al . X protein of hepatitis B 131s inhibits Fas * mediated apoptosis and is associated with up * regulation of the SAPK/JNK pathway.J Biol Chem,2001,276:8 328 - 8 340.
  • 6Shih WL, Kuo ML,Cheuang SE, et al . Hepatitis B virus X protein inhibits transforming growth factor beta - induced apoptosis through the activation of phosphatidy linositol 3 - kinase pathway [J]. Biol Chem,2000,275(33) :25 858- 25 864.
  • 7M arakam i S, Cheong JH, Ohno S, et al . T ransactivation of human HBV X protein, HBX operates through mechanism distinct from protein kinase C and okadaic acid activation pathways [J]. Virology,1994,199:243 - 246.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部